skip to content

Market News

PureTech says Vedanta Biosciences raises USD50m

06 June 2016 07:22

PureTech Health said Vedanta Biosciences has raised USD50m in new equity investments. New investors Rock Springs Capital, Health For Life Capital (Seventure) and Invesco Asset Management were joined by PureTech in the financing.

Vedanta Biosciences is a pioneer in the development of a new class of therapies designed to modulate the human microbiome.

Story provided by

Related Company: PRTC

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?


Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.